Pharmalgen

BNF:
3.4.2
Status:
Red
Decision Date:
March 2012
 

Comments

RED:1,2,4,5 NICE TA246 - started and monitored in a specialist centre. Pharmalgen – a recommended treatment for bee or wasp venom allergy after a severe reaction, or moderate reaction in certain circumstances.

Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
  • 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
  • 4: Specifically designated as “hospital only” by product licence or by DH/NICE
  • 5: Is new to clinical practice and unfamiliar, necessitating a period of accumulation of experience, firstly (and most rapidly) by consultants/specialists

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app